Leisure
Compare Stocks
5 / 10Stock Comparison
OSW vs MNTN vs SKIN vs ELF vs REVG
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Household & Personal Products
Household & Personal Products
Agricultural - Machinery
OSW vs MNTN vs SKIN vs ELF vs REVG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Leisure | Advertising Agencies | Household & Personal Products | Household & Personal Products | Agricultural - Machinery |
| Market Cap | $2.49B | $724M | $118M | $3.44B | $3.12B |
| Revenue (TTM) | $989M | $299M | $296M | $1.52B | $2.40B |
| Net Income (TTM) | $78M | $23M | $-6M | $104M | $108M |
| Gross Margin | 13.7% | 80.0% | 64.9% | 70.3% | 14.4% |
| Operating Margin | 9.4% | 13.8% | -3.6% | 11.1% | 7.1% |
| Forward P/E | 21.7x | 8.9x | — | 19.9x | 17.2x |
| Total Debt | $103M | $0.00 | $379M | $313M | $56M |
| Cash & Equiv. | $16M | $210M | $233M | $149M | $35M |
OSW vs MNTN vs SKIN vs ELF vs REVG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 25 | May 26 | Return |
|---|---|---|---|
| OneSpaWorld Holding… (OSW) | 100 | 131.6 | +31.6% |
| MNTN Inc. (MNTN) | 100 | 33.9 | -66.1% |
| The Beauty Health C… (SKIN) | 100 | 35.6 | -64.4% |
| e.l.f. Beauty, Inc. (ELF) | 100 | 54.1 | -45.9% |
| REV Group, Inc. (REVG) | 100 | 170.4 | +70.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OSW vs MNTN vs SKIN vs ELF vs REVG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OSW carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.12, yield 0.7%
- Lower volatility, beta 1.12, Low D/E 18.9%, current ratio 1.91x
- Beta 1.12, yield 0.7%, current ratio 1.91x
- 7.9% margin vs SKIN's -2.0%
MNTN is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 28.6%, EPS growth 79.8%, 3Y rev CAGR 29.3%
- 28.6% revenue growth vs SKIN's -10.0%
- Lower P/E (8.9x vs 17.2x)
SKIN lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, ELF doesn't own a clear edge in any measured category.
REVG ranks third and is worth considering specifically for long-term compounding.
- 174.2% 10Y total return vs OSW's 157.2%
- +80.3% vs MNTN's -65.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 28.6% revenue growth vs SKIN's -10.0% | |
| Value | Lower P/E (8.9x vs 17.2x) | |
| Quality / Margins | 7.9% margin vs SKIN's -2.0% | |
| Stability / Safety | Beta 1.12 vs ELF's 2.36, lower leverage | |
| Dividends | 0.7% yield, 2-year raise streak, vs REVG's 0.4%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +80.3% vs MNTN's -65.2% | |
| Efficiency (ROA) | 10.8% ROA vs SKIN's -1.2%, ROIC 10.6% vs -6.8% |
OSW vs MNTN vs SKIN vs ELF vs REVG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
OSW vs MNTN vs SKIN vs ELF vs REVG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REVG leads in 2 of 6 categories
MNTN leads 1 • SKIN leads 1 • OSW leads 1 • ELF leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MNTN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
REVG is the larger business by revenue, generating $2.4B annually — 8.1x SKIN's $296M. OSW is the more profitable business, keeping 7.9% of every revenue dollar as net income compared to SKIN's -2.0%. On growth, ELF holds the edge at +37.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $989M | $299M | $296M | $1.5B | $2.4B |
| EBITDAEarnings before interest/tax | $112M | $52M | $9M | $235M | $193M |
| Net IncomeAfter-tax profit | $78M | $23M | -$6M | $104M | $108M |
| Free Cash FlowCash after capex | $65M | $20M | $29M | $215M | $200M |
| Gross MarginGross profit ÷ Revenue | +13.7% | +80.0% | +64.9% | +70.3% | +14.4% |
| Operating MarginEBIT ÷ Revenue | +9.4% | +13.8% | -3.6% | +11.1% | +7.1% |
| Net MarginNet income ÷ Revenue | +7.9% | +7.8% | -2.0% | +6.8% | +4.5% |
| FCF MarginFCF ÷ Revenue | +6.6% | +6.5% | +9.8% | +14.1% | +8.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.7% | +14.2% | -6.7% | +37.8% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +40.0% | +137.9% | +38.0% | +116.7% | +68.6% |
Valuation Metrics
SKIN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 32.2x trailing earnings, ELF trades at a 10% valuation discount to OSW's 35.6x P/E. On an enterprise value basis, REVG's 14.4x EV/EBITDA is more attractive than SKIN's 7331.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.5B | $724M | $118M | $3.4B | $3.1B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $514M | $264M | $3.6B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 35.62x | -105.52x | -5.69x | 32.18x | 33.81x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.68x | 8.94x | — | 19.89x | 17.18x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.79x | — |
| EV / EBITDAEnterprise value multiple | 22.87x | 15.16x | 7331.15x | 17.85x | 14.35x |
| Price / SalesMarket cap ÷ Revenue | 2.59x | 2.50x | 0.39x | 2.62x | 1.27x |
| Price / BookPrice ÷ Book value/share | 4.70x | 15.28x | 2.02x | 4.74x | 7.73x |
| Price / FCFMarket cap ÷ FCF | 36.43x | 12.83x | 3.17x | 29.86x | 16.41x |
Profitability & Efficiency
REVG leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
REVG delivers a 27.9% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-9 for SKIN. REVG carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), SKIN scores 7/9 vs MNTN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.1% | +8.3% | -9.4% | +8.9% | +27.9% |
| ROA (TTM)Return on assets | +10.8% | +6.6% | -1.2% | +4.5% | +8.9% |
| ROICReturn on invested capital | +10.6% | +18.9% | -6.8% | +13.5% | +29.9% |
| ROCEReturn on capital employed | +13.4% | +12.2% | -4.5% | +16.6% | +27.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.19x | — | 6.20x | 0.41x | 0.13x |
| Net DebtTotal debt minus cash | $86M | -$210M | $146M | $164M | $21M |
| Cash & Equiv.Liquid assets | $16M | $210M | $233M | $149M | $35M |
| Total DebtShort + long-term debt | $103M | $0 | $379M | $313M | $56M |
| Interest CoverageEBIT ÷ Interest expense | 7.88x | 14.94x | 0.81x | 6.48x | 6.03x |
Total Returns (Dividends Reinvested)
REVG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REVG five years ago would be worth $36,117 today (with dividends reinvested), compared to $707 for SKIN. Over the past 12 months, REVG leads with a +80.3% total return vs MNTN's -65.2%. The 3-year compound annual growth rate (CAGR) favors REVG at 85.2% vs SKIN's -56.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +19.3% | -24.7% | -35.0% | -20.6% | +2.6% |
| 1-Year ReturnPast 12 months | +32.7% | -65.2% | -35.9% | -7.2% | +80.3% |
| 3-Year ReturnCumulative with dividends | +105.5% | -65.2% | -91.7% | -31.4% | +535.6% |
| 5-Year ReturnCumulative with dividends | +136.3% | -65.2% | -92.9% | +105.0% | +261.2% |
| 10-Year ReturnCumulative with dividends | +157.2% | -65.2% | -91.6% | +133.1% | +174.2% |
| CAGR (3Y)Annualised 3-year return | +27.1% | -29.6% | -56.4% | -11.8% | +85.2% |
Risk & Volatility
Evenly matched — OSW and MNTN each lead in 1 of 2 comparable metrics.
Risk & Volatility
OSW is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than ELF's 2.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OSW currently trades 95.5% from its 52-week high vs MNTN's 28.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.17x | 1.17x | 1.71x | 2.27x | 1.48x |
| 52-Week HighHighest price in past year | $25.75 | $32.49 | $2.69 | $150.99 | $69.92 |
| 52-Week LowLowest price in past year | $18.19 | $7.71 | $0.76 | $58.05 | $34.96 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +28.3% | +33.8% | +40.9% | +91.4% |
| RSI (14)Momentum oscillator 0–100 | 59.1 | 42.2 | 52.1 | 42.3 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 842K | 644K | 760K | 2.3M | 1.6M |
Analyst Outlook
OSW leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: OSW as "Buy", SKIN as "Hold", ELF as "Buy", REVG as "Hold". Consensus price targets imply 124.8% upside for MNTN (target: $21) vs -13.9% for REVG (target: $55). For income investors, OSW offers the higher dividend yield at 0.69% vs REVG's 0.40%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $27.50 | $20.64 | $1.30 | $95.17 | $55.00 |
| # AnalystsCovering analysts | 11 | — | 13 | 27 | 12 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | — | — | — | +0.4% |
| Dividend StreakConsecutive years of raises | 2 | — | — | 1 | 0 |
| Dividend / ShareAnnual DPS | $0.17 | — | — | — | $0.26 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +1.4% | 0.0% | +1.9% | +3.5% |
REVG leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). MNTN leads in 1 (Income & Cash Flow). 1 tied.
OSW vs MNTN vs SKIN vs ELF vs REVG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OSW or MNTN or SKIN or ELF or REVG a better buy right now?
For growth investors, MNTN Inc.
(MNTN) is the stronger pick with 28. 6% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). e. l. f. Beauty, Inc. (ELF) offers the better valuation at 32. 2x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate OneSpaWorld Holdings Limited (OSW) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OSW or MNTN or SKIN or ELF or REVG?
On trailing P/E, e.
l. f. Beauty, Inc. (ELF) is the cheapest at 32. 2x versus OneSpaWorld Holdings Limited at 35. 6x. On forward P/E, MNTN Inc. is actually cheaper at 8. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OSW or MNTN or SKIN or ELF or REVG?
Over the past 5 years, REV Group, Inc.
(REVG) delivered a total return of +261. 2%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: REVG returned +174. 2% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OSW or MNTN or SKIN or ELF or REVG?
By beta (market sensitivity over 5 years), MNTN Inc.
(MNTN) is the lower-risk stock at 1. 17β versus e. l. f. Beauty, Inc. 's 2. 27β — meaning ELF is approximately 95% more volatile than MNTN relative to the S&P 500. On balance sheet safety, REV Group, Inc. (REVG) carries a lower debt/equity ratio of 13% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.
05Which is growing faster — OSW or MNTN or SKIN or ELF or REVG?
By revenue growth (latest reported year), MNTN Inc.
(MNTN) is pulling ahead at 28. 6% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: MNTN Inc. grew EPS 79. 8% year-over-year, compared to -60. 0% for REV Group, Inc.. Over a 3-year CAGR, ELF leads at 49. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OSW or MNTN or SKIN or ELF or REVG?
e.
l. f. Beauty, Inc. (ELF) is the more profitable company, earning 8. 5% net margin versus -3. 2% for The Beauty Health Company — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELF leads at 12. 0% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — MNTN leads at 76. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OSW or MNTN or SKIN or ELF or REVG more undervalued right now?
On forward earnings alone, MNTN Inc.
(MNTN) trades at 8. 9x forward P/E versus 21. 7x for OneSpaWorld Holdings Limited — 12. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNTN: 124. 8% to $20. 64.
08Which pays a better dividend — OSW or MNTN or SKIN or ELF or REVG?
In this comparison, OSW (0.
7% yield), REVG (0. 4% yield) pay a dividend. MNTN, SKIN, ELF do not pay a meaningful dividend and should not be held primarily for income.
09Is OSW or MNTN or SKIN or ELF or REVG better for a retirement portfolio?
For long-horizon retirement investors, OneSpaWorld Holdings Limited (OSW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
17), 0. 7% yield, +159. 6% 10Y return). e. l. f. Beauty, Inc. (ELF) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OSW: +159. 6%, ELF: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OSW and MNTN and SKIN and ELF and REVG?
These companies operate in different sectors (OSW (Consumer Cyclical) and MNTN (Communication Services) and SKIN (Consumer Defensive) and ELF (Consumer Defensive) and REVG (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: OSW is a small-cap quality compounder stock; MNTN is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock; ELF is a small-cap high-growth stock; REVG is a small-cap quality compounder stock. OSW pays a dividend while MNTN, SKIN, ELF, REVG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.